Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in Pulmonary Arterial Hypertension
NCT01179737Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jul 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of nilotinib in pulmonary arterial hypertension (PAH), sponsored by Novartis. Started Jul 2010; status: terminated.
02
Drugs
nilotinib
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT01179737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01179737.